is there a tirzepatide shortage FDA reconsidering its decision to take off its drug list Some patients now turn to

The opacity is gone for the generic market, and it is progressively eroding in the brand market through the DTC pricing transparency that MFN agreements are forcing

In October 2022, Groves learned about Mounjaro on social media and started taking the medication off-label for her PCOS symptoms

This achievement sets a powerful benchmark for innovators and generics developers, bridging the gap between scientific complexity and regulatory expectations

1 Increased awareness of semaglutides weight loss benefits has fueled demand, including for off-label use, contributing to shortages for Ozempic and Wegovy since March 2022